Why AbbVie Stock Is Jumping Today
Shares of (NYSE: ABBV) were jumping 4.2% higher as of 11:37 a.m. ET on Thursday. The nice gain came after the big drugmaker revealed that it had settled litigation with all companies that have filed abbreviated new drug applications (ANDAs) with the U.S. Food and Drug Administration (FDA) to make generic versions of AbbVie's autoimmune disease drug Rinvoq.
AbbVie currently awaits pediatric exclusivity for Rinvoq. If this is granted, the company doesn't expect generic competition for the drug before April 2037 in the U.S.
Image source: Getty Images.
Source Fool.com
AbbVie Inc. Aktie
216,10 €
0,61 %
Rein positive Einschätzungen für AbbVie Inc., nur Buy-Einschätzungen, keine Sell-Einschätzungen.
Die Community prognostiziert für AbbVie Inc. ein Kursziel von 228 €, was einen leichten Anstieg gegenüber 216.1 € darstellt.
